Translational Read-Through Therapy of RPGR Nonsense Mutations
Open Access
- 10 November 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (22) , 8418
Abstract
X-chromosomal retinitis pigmentosa (RP) frequently is caused by mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene. We evaluated the potential of PTC124 (Ataluren, TranslamaTM) treatment to promote ribosomal read-through of premature termination codons (PTC) in RPGR. Expression constructs in HEK293T cells showed that the efficacy of read-through reagents is higher for UGA than UAA PTCs. We identified the novel hemizygous nonsense mutation c.1154T > A, p.Leu385* (NM_000328.3) causing a UAA PTC in RPGR and generated patient-derived fibroblasts. Immunocytochemistry of serum-starved control fibroblasts showed the RPGR protein in a dot-like expression pattern along the primary cilium. In contrast, RPGR was no longer detectable at the primary cilium in patient-derived cells. Applying PTC124 restored RPGR at the cilium in approximately 8% of patient-derived cells. RT-PCR and Western blot assays verified the pathogenic mechanisms underlying the nonsense variant. Immunofluorescence stainings confirmed the successful PTC124 treatment. Our results showed for the first time that PTC124 induces read-through of PTCs in RPGR and restores the localization of the RPGR protein at the primary cilium in patient-derived cells. These results may provide a promising new treatment option for patients suffering from nonsense mutations in RPGR or other genetic diseases.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (1885/1-2, NA 1398/1-1)
- FAUN Stiftung (-)
- ERARE17-114 (NE 2118/2-1)
This publication has 54 references indexed in Scilit:
- Mutations inRPGRandRP2Account for 15% of Males with Simplex Retinal Degenerative DiseaseInvestigative Ophthalmology & Visual Science, 2012
- A comparative evaluation of NB30, NB54 and PTC124 in translational read‐through efficacy for treatment of an USH1C nonsense mutationEMBO Molecular Medicine, 2012
- Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosaProceedings of the National Academy of Sciences, 2012
- Beneficial Read-Through of aUSH1CNonsense Mutation by Designed Aminoglycoside NB30 in the RetinaInvestigative Ophthalmology & Visual Science, 2010
- Aminoglycoside-induced mutation suppression (stop codon readthrough) as a therapeutic strategy for Duchenne muscular dystrophyTherapeutic Advances in Neurological Disorders, 2010
- The molecular basis of human retinal and vitreoretinal diseasesProgress in Retinal and Eye Research, 2010
- Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)Journal of Child Neurology, 2010
- Retinitis Pigmentosa GTPase Regulator (RPGR) protein isoforms in mammalian retina: Insights into X-linked Retinitis Pigmentosa and associated ciliopathiesVision Research, 2008
- Identification and characterization of a novel RPGR isoform in human retinaHuman Mutation, 2007
- RP2 and RPGR Mutations and Clinical Correlations in Patients with X-Linked Retinitis PigmentosaThe American Journal of Human Genetics, 2003